Skip to Content

Hun Ju Lee

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2006 University of Buffalo, Buffalo, NY, MBA, School of Management
2006 University of Buffalo, Buffalo, NY, MD, School of Medicine
2001 University of Buffalo, New York, NY, BS, Magna cum laude, Biochemical Pharmacology

Postgraduate Training

7/2011-6/2012 Clinical Fellowship, Leukemia Fellowship, MD Anderson Cancer Center, Houston, TX
7/2009-6/2011 Clinical Fellowship, Medical Oncology, Roswell Park Cancer Institute, Buffalo, NY
7/2006-6/2009 Clinical Residency, Internal Medicine, Long Island Jewish Medical Center, New Hyde Park, NY

Board Certifications

10/2009 American Board of Internal Medicine

Selected Publications

Peer-Reviewed Original Research Articles

1. Lee HJ, Chihara D, Wang M, Mouhayar E, Kim P. Ibrutinib-related atrial fibrillation in patients with mantle cell lymphoma. Leuk Lymphoma. e-Pub 4/2016. PMID: 27087288.
2. Gallardo M, Lee HJ, Zhang X, Bueso-Ramos C, Pageon LR, McArthur M, Multani A, Nazha A, Manshouri T, Parker-Thornburg J, Rapado I, Quintas-Cardama A, Kornblau SM, Martinez-Lopez J, Post SM. hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies. Cancer Cell 28(4):486-99, 10/2015. e-Pub 9/2015. PMCID: PMC4652598.
3. Jain P, Lee HJ, Qiao W, Wierda W, Benjamini O, Burger J, Ferrajoli A, Estrov Z, Kantarjian H, Keating M, O'Brien S. FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia. Cancer 120(22):3494-501, 11/2014. e-Pub 7/2014. PMCID: PMC4221361.
4. Oki Y, Noorani M, Lin P, Davis RE, Neelapu SS, Ma L, Ahmed M, Rodriguez MA, Hagemeister FB, Fowler N, Wang M, Fanale MA, Nastoupil L, Samaniego F, Lee HJ, Dabaja BS, Pinnix CC, Medeiros LJ, Nieto Y, Khouri I, Kwak LW, Turturro F, Romaguera JE, Fayad LE, Westin JR. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol. e-Pub 6/2014. PMID: 24943107.
5. Lee HJ, Muindi JR, Tan W, Hu Q, Wang D, Liu S, Wilding GE, Ford LA, Sait SN, Block AW, Adjei AA, Barcos M, Griffiths EA, Thompson JE, Wang ES, Johnson CS, Trump DL, Wetzler M. Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. Cancer 120(4):521-9, 2/2014. e-Pub 10/2013. PMCID: PMC3948325.
6. Lee HJ, Daver N, Kantarjian HM, Verstovsek S, Ravandi F. The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia. Clin Cancer Res 19(2):327-35, 1/2013. e-Pub 12/2012. PMID: 23209034.
7. Lee HJ, Licht AS, Hyland AJ, Ford LA, Sait SN, Block AW, Barcos M, Baer MR, Wang ES, Wetzler M. Is obesity a prognostic factor for acute myeloid leukemia outcome? Ann Hematol 91(3):359-65, 3/2012. e-Pub 9/2011. PMID: 21935651.
8. Lee HJ, Thompson JE, Wang ES, Wetzler M. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: Current Treatment and Future Perspectives. Cancer 117(8):1583-94, 4/2011. e-Pub 11/2010. PMID: 21472706.
9. Lee HJ, Johnson CS, Trump D, Wetzler M. Vitamin D and Acute Myeloid Leukemia, Acute Leukemia - The Scientist's Perspective and Challenge. Intechopen, 2011.
10. Armand P, Deeg HJ, Kim HT, Lee HJ, Armistead P, de Lima M, Gupta V, Soiffer RJ. Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromes. Bone Marrow Transplant 45(5):877-85, 5/2010. e-Pub 9/2009. PMCID: PMC2868955.
11. Nguyen DM, Lee HJ, Mirabella D, Wu DW. Delayed Hemolytic Transfusion Reaction Due to Anti-JKb. Case Report Highlighting the Importance of Early Blood Bank Consultation and Literature Review. NAJMS(4):187-193, 2010.
12. Lee HJ, Gulbis A, De Padua Silva L, Hosing C, Khouri I, de Lima M, Champlin RE, Ciurea SO. Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT. Bone Marrow Transplant 42(1):67-9, 7/2008. e-Pub 3/2008. PMID: 18347568.
13. Lee HJ, Oran B, Saliba RM, Couriel DM, Shin K, Massey P, Neumann J, de Lima M, Champlin R, Giralt S. Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy. Bone Marrow Transplant 38(4):299-303, 8/2006. e-Pub 7/2006. PMID: 16819437.
14. Gandhi V. Activity of the CD40 antagonistic antibody lucatumumab – insights from CLL-niche mimicking xenografts and fludarabine combinations. Leukemia and Lymphoma. Submitted.


1. Lee, HJ, Gallardo, M, Zhang, X, Quintas-Cardama, A, Post, SM. p53 Pathway Alterations Influence Survival and Treatment Response In Chronic Lymphocytic Leukemia. Blood (ASH Annual Meeting Abstracts) 122(21):2885, 12/2013.
2. Quintas-Cardama A, Zhang X, Attieh Y, Lee HJ, Qiu YH, Kornblau S, Post S. hnRNP K: A Putative Regulator of Leukemogenesis and the p53 Pathway. Blood (ASH Annual Meeting Abstracts) 120:774, 11/2012.
3. Lee HJ, Kantarjian HM, Thomas DA, Faderl S, Koller C, Ferrajoli A, Jabbour E, Garris R, Kebriaei P, Champlin R, Borthakur G, Wierda WG, Burger JA, Cortes JE, O'Brien S, Ravandi F. Long-Term Follow-up of Combined Hypercvad (hCVAD) Regimen with Dasatinib (Db) in the Front Line Therapy of Patients (pts) with Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL). Blood (ASH Annual Meeting Abstracts) 118:1512, 11/2011.
4. Lee HJ, O'Brien S, Kantarjian HM, Ravandi F, Faderl S, Koller C, Konopleva M, Verstovsek S, Kadia T, Garcia-Manero G, Borthakur G, Wierda WG, Burger JA, Thomas DA, Cortes JE. Outcome of Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Relapse After Tyrosine Kinase Inhibitor (TKI) Therapy. Blood (ASH Annual Meeting Abstracts) 118:1518, 11/2011.
5. Lee HJ, Muindi J, Wei T, Wilding G, Ford LA, Sait S, Block A, Barcos M, Vigil CE, Griffiths EA, Thompson JA, Wang ES, Johnson CS, Trump D, Wetzler M. Subnormal Vitamin D Levels Are Associated with Adverse Outcome In Newly-Diagnosed Similarly-Treated Adult Acute Myeloid Leukemia (AML) Patients. Blood (ASH Annual Meeting Abstracts) 116:1041, 11/2010.

Last updated: 8/30/2016